Lyell Immunopharma, Inc.
LYEL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001806952
In the last 90 days, Lyell Immunopharma, Inc. insiders filed 0 open-market purchases and 10 sales; 87 institutions reported holding it in 13F filings for Q2 2026, worth $178.0M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Lyell Immunopharma, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 52 | +52 |
| Shares | 0 | 79.7M | +79.7M |
| Value | $0 | $1.29B | +$1.29B |
New holders (52)
Institutions that held Lyell Immunopharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (0)
Institutions that held Lyell Immunopharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.